Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
M.KhanI.et al (2022b)
SYMLIN therapy should only be considered in patients with type 1 diabetes or patients with type 2 diabetes using mealtime insulin who fulfill the following criteria: have failed to achieve adequate glycemic control despite individualized insulin management
Nutrients, 14(8), 1612.
Environment International, 125: 117124 Wang B, Liu S, Zhou A, Xu M, Yang D, Su K (2021a)
Germany 1994 - Young Investigator Award (American Federation for Clinical Research)
US$ 28.22
US$ 28.58
US$ 25.42
US$ 20.32
US$ 23.86
US$ 29.44
